Skip to content

Natural-Knee II Patellofemoral Joint Prosthesis

by Sulzer Orthopedics, Inc.

510(k) K002356

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK002356 Date30 Oct 2000ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KRR
Device Class
Class II
Regulation
21 CFR Part 888.3540
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Natural-Knee II Patellofemoral Joint Prosthesis is a semi-constrained, cemented knee prosthesis designed to replace the patellofemoral joint. It is classified as a Prosthesis, Knee, Patellofemoral, Semi-Constrained, Cemented, Metal/Polymer device, intended for use in orthopedic surgery to address patellofemoral joint issues such as primary patellofemoral arthritis or chondromalacia.

This device is implanted during surgery and secured with bone cement. It limits translation and rotation through the geometry of its articulating surfaces, providing stability to the patellofemoral joint. Supplied as a sterile, single-use implant, it is regulated under FDA 510(k) clearance (K002356) and falls under product code KRR, classified as a Class II medical device. Multiple femoral and tibial component sizes are available to accommodate varying patient anatomies.

Other devices from Sulzer Orthopedics, Inc.

See all devices from Sulzer Orthopedics, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of knee issues is the Natural-Knee II Patellofemoral Joint Prosthesis designed to address in patients?

    The Natural-Knee II Patellofemoral Joint Prosthesis is specifically designed to address patellofemoral joint issues such as primary patellofemoral arthritis or chondromalacia. It is intended for use in orthopedic surgery to restore function and stability to the patellofemoral joint in patients experiencing degenerative or damaged cartilage in this area.

  • How is the Natural-Knee II Patellofemoral Joint Prosthesis secured in place during surgery?

    The prosthesis is secured using bone cement, which is applied during surgery to firmly attach the implant to the patient’s femur and patella. This cemented fixation ensures stability and longevity of the implant.

  • Is the Natural-Knee II Patellofemoral Joint Prosthesis intended for single-use or can it be reused?

    The Natural-Knee II Patellofemoral Joint Prosthesis is supplied as a sterile, single-use implant. It is not designed for reuse after surgical implantation.

  • What range of sizes is available for the Natural-Knee II Patellofemoral Joint Prosthesis to accommodate different patient anatomies?

    Multiple femoral and tibial component sizes are available to fit varying patient anatomies. The exact sizes are listed in the provided FEI numbers (e.g., 3005706667, 1000114185, etc.), which correspond to specific component dimensions tailored for different knee structures.

  • What regulatory pathway was followed for the FDA clearance of the Natural-Knee II Patellofemoral Joint Prosthesis?

    The Natural-Knee II Patellofemoral Joint Prosthesis received FDA clearance through the 510(k) pathway, specifically under the traditional review process. It was determined to be substantially equivalent to a legally marketed predicate device and was reviewed by the Orthopedic (OR) Advisory Committee.